Fagron N.V.

Stocks

FAGR

BE0003874915

Market Closed - Euronext Bruxelles Other stock markets 09:05:09 11/06/2026 pm IST			5-day change	1st Jan Change
24.40 ^EUR	-1.21%		+3.83%	+14.55%

15/05	Fagron Receives FDA Warning Letter Over IV Bag-related Product Issues	MT
15/05	Fagron update on FDA communication regarding 2025 inspection	RE

Transcript : Fagron NV, 2025 Earnings Call, Feb 12, 2026

Published on 02/17/2026 at 03:34 am IST

S&P Capital IQ

Presenter Speech
Ignacio Artola (Executives)

Hello, and good morning, everyone. Welcome to Fagron's Full Year 2025 Results Webcast. I'm joined today by our CEO, Rafael Padilla; and our CFO, Karin de

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Fagron N.V.

15/05	Fagron Receives FDA Warning Letter Over IV Bag-related Product Issues	MT
15/05	Fagron update on FDA communication regarding 2025 inspection	RE
11/05	Fagron NV Approves Board Appointments	CI
11/05	Fagron NV Approves the Distribution of a Gross Dividend, Payable on 20 May 2026	CI
13/04	Berenberg Notes Fagron's Q1 Growth in All Regions; Buy Reaffirmed	MT
10/04	Fagron NV, Q1 2026 Sales/ Trading Statement Call, Apr 09, 2026
09/04	Fagron Seeks Acquisitions	CI
09/04	Fagron posts Q1 revenue of EUR 263 million	RE
09/04	Fagron NV Reports Revenue Results for the First Quarter Ended 31 March 2026	CI
03/03	Fagron Acquires Pharmaceutical Packaging Provider Vepakum	MT
03/03	Fagron completes acquisition of Vepakum	RE
27/02	Fagron Wraps Up EUR68 Million Purchase of Pharmavit Europe	MT
26/02	Fagron completes strategic acquisition of Pharmavit Europe	RE
26/02	Fagron NV acquired Pharmavit Europe B.V. for ?68 million.	CI
17/02	Fagron NV, 2025 Earnings Call, Feb 12, 2026